B S D M E D I C A L

A company specializing in BioSystems Design

Press Releases

To automatically receive all Press Releases via email please submit the following:

Name:
Email Address:

Click on highlighted date to view the Press Release of your choice.

  • February 8, 2005 -- “BSD Medical Leading the Way for New Entrepreneurial Front”-Utah Business Magazine
  • February 1, 2005 -- BSD Medical Receives Escrow Payment Released from TherMatrx Sale
  • January 12, 2005 -- BSD Medical’s Revolutionary Application for MRI Published in Leading Cancer Journal
  • December 14, 2004 -- BSD Medical Opens Chinese Market with First Sale of Advanced Cancer Treatment System
  • December 7, 2004 -- FDA Grants BSD Medical IDE Approval to Enhance High-end Cancer Treatment System
  • November 11, 2004 -- BSD Medical Signs Best Medical International as U.S. Sales Agent
  • October 26, 2004 -- NYU Cancer Center Features New System by BSD Medical
  • October 13, 2004 -- New Hyperthermia System by BSD Medical to Treat Pelvic Cancers in 2,400 Bed Hospital
  • October 5, 2004 -- BSD Medical Corp. Sponsors Symposium and Displays Products at ASTRO
  • September 28, 2004 -- BSD Medical Corp. Enters China Market through Agreement with Dalian Orientech
  • September 8, 2004 -- BSD Medical Corporation Unveils Its Prime Initiatives Following Major Cash Infusion
  • July 15, 2004 -- BSD Medical Corporation Concludes the Sale of Its Holdings in TherMatrx, Inc.
  • June 18, 2004 -- BSD Medical Corporation Comments on the Sale of Its Holdings in TherMatrx, Inc.
  • June 16, 2004 -- BSD Medical Corporation Sells Its Holdings in TherMatrx, Inc.
  • May 25, 2004 -- BSD Medical’s Hyperthermia Systems—Patient Friendly Treatment for Rectal Cancer
  • May 11, 2004 -- BSD Medical Receives FDA Approval to Investigate New Cancer Treatment Applicator
  • May 6, 2004 -- TherMatrx Receives New FDA Approval - New Catheter Expands Patient Group for Dose Optimized Thermotherapy
  • April 22, 2004 -- BSD Medical’s Chairman Nominated for “Entrepreneur of the Year”
  • April 20, 2004 -- BSD Medical to Present Major Technology Advances at World Hyperthermia Conference
  • March 23, 2004 -- Hyperthermia and Chemotherapy Combo Winning Against Cancer in Germany
  • February 17, 2004 -- BSD Medical Receives New FDA Approval -- Targets Better Treatment of Prostate, Breast and Cervical Cancer
  • January 27, 2004 -- GYN Cancer - Hot Target for New System by BSD Medical
  • January 15, 2004 -- Prime Time Television Introduces BSD Medical’s Technology in New Super-Therapy for Cancer
  • January 9, 2004 -- Prime Time German Television to Feature BSD Medical’s Groundbreaking Cancer Therapy
  • December 19, 2003 -- Medical Reimbursement for TherMatrx BPH Therapy Increased by 50%
  • December 1, 2003 -- BSD Medical Corporation Raises $2 Million in Private Placement
  • November 13, 2003 -- Swiss Government Opens the Way to Commercialization of the BSD-2000
  • November 4, 2003 -- Long Beach Memorial Débuts BSD Medical’s Newly FDA Approved Cancer Treatment System
  • October 27, 2003 -- BSD Medical Announces FDA Approval of New Cancer Treatment Systems at National Conference
  • October 14, 2003 -- BSD Medical Receives FDA Approval for New Systems Used in Cancer Treatment
  • September 23, 2003 -- BSD Medical Technology Opens Exploration into New Super-Therapy for Cancer
  • August 12, 2003 -- BSD Medical’s Innovative Technology Could Spare ‘the Majority’ of Limb Cancer Patients from Amputation
  • July 30, 2003 -- BSD Medical Adds a Powerful Punch to Cervical Cancer Treatment
  • July 16, 2003 -- BSD Medical Corp. Receives High Marks in Routine FDA Audit
  • July 1, 2003 -- Microwaves Help Children Beat the Odds in Cancer Survival
  • June 11, 2003 -- New cancer treatment system “sees” temperatures to within half a degree
  • December 17, 2002 -- BSD Medical Announces Fourth Quarter Net Income of $294,559—Turning Year-end Net Income Positive
  • November 20, 2002 -- Researchers Observe “Mitotic Catastrophe” in Cancer after Hyperthermia
  • November 12, 2002 -- BSD Medical Introduces New Cancer Treatment Systems at Three Medical Conferences
  • September 4, 2002 -- Lancet Oncology Review—Combining Hyperthermia with the Major Cancer Therapies
  • July 11, 2002 -- Grand Opening Unveils ‘New Form of Cancer Treatment’  Intensifying the Effect of Chemotherapy and Radiation
  • June 6, 2002 -- TherMatrx Sales Run Away from the Competition
  • May 22, 2002 -- Nucletron and BSD Medical team up in war against cancer
  • March 19, 2002 -- BSD Medical Acquires Additional FDA Approval
  • February 26, 2002 -- BSD Medical Acquires NIH License Rights Following Success with MRI Treatment Monitoring
  • January 14, 2002 -- TherMatrx Sales Explode—BSD Medical Supplies Hundredth BPH System
  • November 30, 2001 -- BSD Medical Corporation Announces Quarterly/Year-End Results Fourth Quarter Net Income at 21% of Sales
  • October 23, 2001 -- BSD Medical’s new MRI-integrated cancer therapy welcomed by Japanese
  • October 2, 2001 -- Hyperthermia and hypoxia spell cancer destruction—THE LANCET
  • August 14, 2001 -- BSD Medical Honored by Double Distinctions
  • July 16, 2001 -- BSD Medical Corporation Announces Third Quarter Earnings
  • July 3, 2001 -- TherMatrx Receives FDA Approval for New BPH Therapy
  • May 17, 2001 -- ASCO Presentations Show Hyperthermia Enhances Cancer Drug Delivery
  • May 1, 2001 -- NAHS Conference Projects ‘Resurgence’ for Hyperthermia
  • April 11, 2001 -- Erlangen University Joins Prestigious Team of BSD-2000 Based Hyperthermia Treatment Centers
  • March 29, 2001 -- BSD Medical Introducing Dynamic New Use for MRI
  • February 27, 2001 -- March Reader’s Digest Features Hyperthermia as “Hot Cancer Regimen”
  • February 20, 2001 -- Chicago Tribune Lauds Prostate Cancer Treatment Development with BSD-2000
  • February 8, 2001 -- World Review by Leading Researchers Reports Progress of Hyperthermic Oncology
  • January 8, 2001 -- Study Offers New Breakthrough for Cancer Patients
  • December 14, 2000 -- Hyperthermia Holds New Hope for Victims of Rectal Cancer
  • December 9, 2000 -- BSD Medical Issues Fiscal 2000 Year End Report
  • November 6, 2000 -- BSD Medical Broadcasts Hyperthermia at National Radiation Oncology Convention
  • August 31, 2000 -- BSD Medical Places BSD 2000 in 3 Prominent European Facilities
  • August 30, 2000 -- TherMatrx, Inc. Comments on Recently Announced HCFA Levels for Transurethral Microwave Thermotherapy
  • July 25, 2000 -- Duke Receives $18 Million Hyperthermia Grant—Six of Nine Protocols Use BSD-2000
  • July 19, 2000 -- BSD Medical Releases Third Quarter Results
  • June 27, 2000 -- BSD Hires Investor Relations Firm
  • June 14, 2000 -- BSD Medical Sees Clinton’s Medicare Order as Boon for Small Biotech Firms
  • June 8, 2000 -- BSD Medical Corporation’s Third Quarter Sales Top $865,000
  • June 6, 2000 -- BSD Medical Hires Dr. Mark Hagmann, Reports on Need for Expansion
  • May 11, 2000 -- BSD Medical Plays Prominent Role in World Hyperthermia Congress
  • April 25, 2000 -- BSD Medical Receives FDA Approval for Ovarian Cancer Study at Duke University
  • March 31, 2000 -- THE LANCET Reports Six Year Study Showing Success in Treating Cervical Cancer--Trials Used BSD-2000 Deep Regional Hyperthermia System
  • March 21, 2000 -- BSD Medical Emphasizes Scope of EORTC Cancer Research
  • March 17, 2000 -- BSD Medical Announces Quantum Advance in 3D Hyperthermia Control
  • March 9, 2000 -- Ovarian Cancer Targeted by Duke University Liposome Study Using BSD-2000
  • March 1, 2000 -- Duke University Joins EORTC in Phase III Trials Using the BSD-2000
  • February 22, 2000 -- BSD Medical Shares Up 1500%—Issues Eighteen Month Milestone Report
  • February 22, 2000 -- National Television Introduces BSD Medical and Hyperthermia to America
  • February 16, 2000 -- National Television to Feature BSD Medical and Hyperthermia
  • February 3, 2000 -- Duke University Studies Define the Therapeutic Role of Hyperthermia
  • January 27, 2000 -- BSD Announces Receipt of CE Mark for Proprietary BSD-2000/3D System
  • January 25, 2000 -- Duke University Reports Progress in Treating Sarcomas with BSD Equipment
  • December 9, 1999 -- Backlog Surges for BSD Medical Corporation
  • November 30, 1999 -- BSD Hires Director of U.S. Sales
  • November 11, 1999 -- BSD Medical Acquires Exclusive License to Tumor-Destroying Hyperthermia Treatment
  • November 2, 1999 -- CNBC to Feature Hyperthermia as a "Powerful Tool" in Cancer Treatment
  • October 8, 1999 -- Hyperthermia Makes Radiation and Chemotherapy More Effective
  • August 24, 1999 -- Hyperthermia Reimbursed as First Line Therapy for Cervical Cancer
  • August 17, 1999 -- BSD Medical Corporation Announces Appointment of New President
  • July 28, 1999 -- BSD Medical Corporation Announces BSD-2000/3D Deep Hyperthermia System Shipment to Rotterdam, The Netherlands
  • June 3, 1999 -- BSD’s Hyperthermia Equipment Provides Optimum Performance - Data Reported at North American Hyperthermia Society Meeting
  • May 18, 1999 -- BSD Medical Announces Clinical Acceptance of Noninvasive Hyperthermia Cancer Treatment and Monitoring
  • April 29, 1999 -- BSD Medical Announces Second $3.25 Million Capital Infusion Into TherMatrx
  • March 31, 1999 -- BSD Appoints Dr. Bill Williams as Director of Marketing and Sales
  • January 27, 1999 -- European Patent Issued to BSD for New Cancer Treatment Device
  • January 20, 1999 -- BSD Receives ISO Certification for Hyperthermia/Thermotherapy Devices
  • December 11, 1998 -- BSD Medical Reports Increased Revenues and Net Income for 1998
  • December 9, 1998 -- Non-Invasive Treatment Monitoring Demonstrated in the Clinic
  • July 9, 1998 -- BSD Medical Conference Results -- Hyperthermia Increases Cancer Patient Survival
  • May 26, 1998 -- BSD Medical Corporation, TherMatrx, Incorporated, and Urologix, Incorporated Jointly Announce Settlement Agreement
  • May 7, 1998 -- BSD Medical Announces the Availability of a Sophisticated Planning System for Use with the New BSD-2000/3D hyperthermia System
  • January 13, 1998 -- Dr. Michael Nobel Joins BSD's Board of Directors
  • January 6, 1998 -- BSD Medical Announces Significant Court Ruling in License Litigation with Urologix, Incorporated
  • November 24, 1997 -- BSD Medical and Oracle Strategic Partners Form TherMatrx to Address $3 Billion Benign Prostatic Hyperplasia Market
  • July 28, 1997 -- Government of Bavaria, Germany Approves Reimbursement of BSD-2000
  • November 13, 1996 -- BSD Medical Corporation Announces $1.5 Million License Agreement with EDAP Technomed, Inc.
  • October 14, 1996 -- BSD Medical Corporation Announces Purchase Order for New Generation of Regional Hyperthermia System
  • September 8, 1995 -- National Cancer Institute Awards Grant to BSD Medical
  • May 8, 1995 -- BSD Medical Announces Resignation
  • December 16, 1994 -- BSD Medical Announces New Chairman and Board of Directors

If you would like copies of older Press Releases or have any specific questions, please send your request to investor@bsdmc.com.

Home ] Company Profile ] News & Media ] Feedback ] Table of Contents ] Search ]
Copyright © 2005 BSD Medical Corporation. All rights reserved. Revised: 02/08/2005